The typical protocol involves injecting the peptides Monday through Friday with weekends off over a ten-week cycle
H.et al (2019)
BPC-157 is a targeted therapy for tissue repair and recovery
The review confirmed BPC-157s angiomodulatory profile, noting that VEGF, Factor VIII, and CD34 peak in the early wound interval and that BPC-157 exhibits angiogenic effects exceeding those of standard agents in the sponge assay
This product is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease
Name CJC-1295 Concentration 5mg per vial Form Lyophilized powder Purity 99%, confirmed by HPLC and MS Packaging Sterile, sealed vial Storage -20C in a dark, dry environment Documentation Certificate of Analysis (COA) available upon request CJC-1295 is a synthetic peptide that acts as a Growth Hormone-Releasing Hormone (GHRH) analog